IC
Ikarian Capital Portfolio holdings
AUM
$302M
This Quarter Return
+0.62%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$437M
AUM Growth
+$437M
(-22%)
Cap. Flow
-$126M
Cap. Flow
% of AUM
-28.81%
Top 10 Holdings %
Top 10 Hldgs %
31.44%
Holding
211
New
18
Increased
20
Reduced
105
Closed
27
Top Buys
| 1 |
BCYC
Bicycle Therapeutics
BCYC
|
$21.9M |
| 2 |
Apellis Pharmaceuticals
APLS
|
$11.5M |
| 3 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
$9.39M |
| 4 |
Immatics
IMTX
|
$8.55M |
| 5 |
Zentalis Pharmaceuticals
ZNTL
|
$6.15M |
Top Sells
| 1 |
Biogen
BIIB
|
$26.5M |
| 2 |
Alector
ALEC
|
$14.1M |
| 3 |
CRISPR Therapeutics
CRSP
|
$10.3M |
| 4 |
Annovis Bio
ANVS
|
$8.86M |
| 5 |
Cullinan Oncology
CGEM
|
$7.61M |
Sector Composition
| 1 | Healthcare | 97.59% |
| 2 | Consumer Staples | 0.77% |
| 3 | Technology | 0.56% |
| 4 | Financials | 0.17% |
| 5 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
InflaRx
IFRX
$117M
| $1.63M | 0.12% |
631,048
-35,548
| -5% | -$92K |
|
|
NTBL
77
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
| $1.62M | 0.11% |
790,838
-9,973
| -1% | -$20.5K |
|
|
CERE
78
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $1.57M | 0.11% |
+53,370
| New | +$1.57M |
|
79
Avalo Therapeutics
AVTX
$139M
| $1.57M | 0.11% |
718,705
-178,625
| -20% | -$388K |
|
80
Cyclerion Therapeutics
CYCN
$7.75M
| $1.54M | 0.11% |
502,627
-7,297
| -1% | -$22.4K |
|
81
Pliant Therapeutics
PLRX
$105M
| $1.46M | 0.1% |
86,712
-21,988
| -20% | -$371K |
|
82
CASI Pharmaceuticals
CASI
$36.1M
| $1.46M | 0.1% |
1,223,067
-45,087
| -4% | -$53.7K |
|
|
BLCM
83
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $1.45M | 0.1% |
496,756
-3,244
| -0.6% | -$9.48K |
|
84
GRI Bio
GRI
$3.67M
| $1.44M | 0.1% |
198,085
+58,085
| +41% | +$360K |
|
85
Mustang Bio
MBIO
$11.1M
| $1.36M | 0.1% |
506,033
-19,970
| -4% | -$52.4K |
|
|
OKUR
86
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$38.3M
| $1.3M | 0.09% |
+175,000
| New | +$1.3M |
|
87
Black Diamond Therapeutics
BDTX
$164M
| $1.27M | 0.09% |
150,484
-3,457
| -2% | -$29.2K |
|
88
DiaMedica Therapeutics
DMAC
$274M
| $1.25M | 0.09% |
311,041
-103,959
| -25% | -$417K |
|
89
Solid Biosciences
SLDB
$448M
| $1.25M | 0.09% |
521,155
-154,520
| -23% | -$369K |
|
90
Quantum-Si Incorporated
QSI
$217M
| $1.2M | 0.08% |
144,406
-15,594
| -10% | -$130K |
|
|
AGTC
91
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $1.18M | 0.08% |
390,394
-25,490
| -6% | -$76.7K |
|
92
Anebulo Pharmaceuticals
ANEB
$101M
| $1.16M | 0.08% |
172,309
-2,502
| -1% | -$16.8K |
|
93
Merus
MRUS
$5.04B
| $1.12M | 0.08% |
50,907
-316
| -0.6% | -$6.95K |
|
94
Corbus Pharmaceuticals
CRBP
$121M
| $968K | 0.07% |
948,526
-15,574
| -2% | -$15.9K |
|
|
BCLI
95
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $955K | 0.07% |
289,550
-3,650
| -1% | -$12.1K |
|
|
HARP
96
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $879K | 0.06% |
111,292
-2,308
| -2% | -$18.2K |
|
97
Tempest Therapeutics
TPST
$46.6M
| $851K | 0.06% |
58,803
-31,062
| -35% | -$450K |
|
|
RGLS
98
DELISTED
Regulus Therapeutics
RGLS
| $849K | 0.06% |
1,228,416
-17,573
| -1% | -$12.1K |
|
|
HEPA
99
DELISTED
Hepion Pharmaceuticals
HEPA
| $847K | 0.06% |
553,273
-811,786
| -59% | -$1.24M |
|
|
ONCT
100
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $830K | 0.06% |
199,180
-1,024
| -0.5% | -$4.25K |
|